Eradicating Ebola: In U.S. Biomedical Research, We Trust
National Institutes of Health (NIH) sent this bulletin at 08/28/2014 11:32 AM EDTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to NIH Director's Blog for National Institutes of Health (NIH).
08/11/2014 10:05 AM EDT
Updated August 28, 2014: Today, the National Institutes of Health (NIH) announced plans to begin initial human testing of an investigational vaccine to prevent Ebola virus disease. Testing of the vaccine, co-developed by NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and GlaxoSmithKline, will begin next week at the NIH Clinical Center in Bethesda, […]
Update Your E-mail Address | Add Subscriptions | Unsubscribe
If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact NIHinfo@od.nih.gov. Before writing, please view our Frequently Asked Questions page, our A-Z Health Topics page, or Search our website.
This service is provided to you by the National Institutes of Health.
NIH…Turning Discovery Into Health®
 |